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Down’s syndrome is a chromosomal disorder that invariably results in both intellectual 
disability and Alzheimer’s disease neuropathology. However, only a limited number of studies 
to date have investigated intrinsic brain network organisation in people with Down’s syndrome, 
none of which addressed the links between functional connectivity and Alzheimer’s disease. 
In this cross-sectional study, we employed 11C-Pittsburgh Compound-B (PiB) positron 
emission tomography in order to group participants with Down’s syndrome based on the 
presence of fibrillar beta-amyloid neuropathology. We also acquired resting state functional 
magnetic resonance imaging data to interrogate the connectivity of the default mode network; 
a large-scale system with demonstrated links to Alzheimer’s disease. The results revealed 
widespread positive connectivity of the default mode network in people with Down’s syndrome 
(n = 34, ages 30 – 55, median age = 43.5) and a stark lack of anti-correlation. However, in 
contrast to typically developing controls (n = 20, ages 30 – 55, median age = 43.5), the Down’s 
syndrome group also showed significantly weaker connections in localised frontal and 
posterior brain regions. Notably, while a comparison of the PiB negative Down’s syndrome 
group (n = 19, ages 30 – 48, median age = 41.0) to controls suggested that alterations in default 
mode connectivity to frontal brain regions are related to atypical development, a comparison 
of the PiB positive (n = 15, ages 39 – 55, median age = 48.0) and PiB negative Down’s 
syndrome groups indicated that aberrant connectivity in posterior cortices is associated with 
the presence of Alzheimer’s disease neuropathology. Such distinct profiles of altered 
connectivity not only further our understanding of the brain physiology that underlies these 
two inherently linked conditions, but may also potentially provide a biomarker for future 




Down’s syndrome, or trisomy 21, is the most common identified cause of intellectual disability 
worldwide (Bittles, Bower, Hussain, & Glasson, 2007; Contestabile, Benfenati, & Gasparini, 
2010; Dierssen, 2012), and is also strongly associated with the development of amyloidosis – 
a hallmark of Alzheimer’s disease. The amyloid cascade hypothesis (Hardy & Higgins, 1992; 
Selkoe, 1991) suggests that this increased risk is due to the supernumerary copy of the amyloid 
precursor protein (APP) gene that is present in Down’s syndrome, which in turn is posited to 
increase the levels of beta amyloid (Aβ) present in the brain. Indeed, histological studies have 
found Aβ plaques in the brains of children and teenagers with Down’s syndrome (Lemere et 
al., 1996; Leverenz & Raskind, 1998), while this neuropathology appears in nearly 100% of 
people with Down’s syndrome over 40 years of age (Mann, 1988). Moreover, studies of people 
with Down’s syndrome using positron emission tomography (PET) and radioligands such as 
11C Pittsburgh Compound-B (11C-PiB) and 18F Florbetaben have demonstrated the presence of 
fibrillar Aβ is detectable in a very high proportion of people by age 50  (Annus et al., 2015; 
Hartley et al., 2017; Hartley et al., 2014; Jennings et al., 2015; Lao et al., 2016; Lao et al., 
2017).  
 
In the typically developing population with Alzheimer’s disease, the topography of amyloid 
deposition is known to overlap substantially with regions that form a large-scale functional 
brain network known as the default mode network (DMN) (Buckner et al., 2009; Buckner et 
al., 2005). Encompassing the medial prefrontal cortex, medial temporal lobe structures, 
posterior cingulate cortex, precuneus, and the angular gyri bilaterally (Andrews-Hanna, 
Smallwood, & Spreng, 2014), the regions that form this network have been reported to show a 
high degree of both functional and structural connectivity (Horn, Ostwald, Reisert, & 
Blankenburg, 2014) with notably high levels of metabolic activity during resting state 
conditions in healthy participants (Gusnard, Raichle, & Raichle, 2001). In patients with 
amnesic symptoms, however, PET imaging studies using 18fluorodeoxyglucose (18FDG) have 
shown that specific regions within this network, including the posterior cingulate and medial 
temporal lobe structures, display hypometabolism (Nestor, Fryer, Smielewski, & Hodges, 
2003). In parallel, a recent study has suggested that amyloid deposition begins in key hubs of 
the DMN, such as the precuneal, medial orbitofrontal and posterior cingulate cortices 
(Palmqvist et al., 2017). Furthermore, several studies have also demonstrated reduced 
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functional connectivity of the DMN in people with Alzheimer’s disease at rest (Gili et al., 2011; 
Greicius, Srivastava, Reiss, & Menon, 2004; He et al., 2007; Yi et al., 2015; Zhou et al., 2010). 
From a cognitive perspective, in addition to being implicated in internal mentation processes 
understood to govern such states of rest (Andrews-Hanna et al., 2014; Mason et al., 2007), 
several studies have also shown that it is associated with a variety of memory-based cognitive 
tasks (Piccoli et al., 2015; Vatansever, Manktelow, Sahakian, Menon, & Stamatakis, 2016; 
Vatansever, Menon, Manktelow, Sahakian, & Stamatakis, 2015; Vatansever, Menon, & 
Stamatakis, 2017). 
 
On the other hand, investigations into the DMN’s functional connectivity architecture in people 
with Down’s syndrome have been limited, with only a small number of studies reporting on 
increased inter-network connectivity of the DMN in this population (Anderson et al., 2013; 
Vega, Hohman, Pryweller, Dykens, & Thornton-Wells, 2015). Despite the demonstrated links 
to both Alzheimer’s disease pathology and the DMN, there has been no investigation into this 
network’s neurodevelopmental alterations in people with Down’s syndrome, nor of the 
potential additive influence of Alzheimer’s disease neuropathology.  
 
As such, the present study employed multimodal neuroimaging techniques (fMRI and 11C-PiB 
PET) with the aim of (a) determining potential functional connectivity alterations of the DMN 
in people with Down’s syndrome, (b) examining the relationship between DMN connectivity 
and age, IQ, and performance on tasks of memory and executive function in people with 
Down’s syndrome, and (c) investigating differences in DMN connectivity in people with 
Down’s syndrome with and without fibrillar Aβ accumulation, indicative of Alzheimer’s 
disease neuropathology.  
 
Materials and Methods 
 
Participants 
Ethical review and approval of this study was provided by the National Research Ethics Service 
– East of England Committee. The majority of participants in this study were able to provide 
informed consent. However, in the minority of cases where participants were not able to 
consent for themselves, the procedures outlined in the Mental Capacity Act (2005) were 
followed, and an appropriate consultee was identified who provided permission for the person 
 5 
with Down’s syndrome to participate, while the participant provided their assent. A total of 36 
participants with Down’s syndrome underwent neuropsychological testing, resting state fMRI 
and 11C-PiB PET. However, one participant was excluded from subsequent analysis due to the 
presence of ventriculomegaly, which prevented registration to standard templates, and another 
was excluded due to suspected co-morbid Parkinson’s disease. Therefore, a total of 34 people 
with Down’s syndrome were included (Table 1). A group of 20 age-matched typically 
developing control participants underwent resting state fMRI only.  
 
Table 1 – Demographic data for the participant cohort. 
 Controls Down’s syndrome 
Number  20 34 
Gender (% female) 45 53 
Median Age  43.5 43.5  





The CAMDEX-DS (S. Ball, 2006) battery was administered to all participants with Down’s 
syndrome. The battery comprises an informant interview (the CAMDEX-DS) and a 
neuropsychological examination of the participant (the CAMCOG-DS). 
 
The diagnosis of dementia was based on findings from the CAMDEX informant interview, 
conducted with an informant who had known the participant for at least the last six months at 
the time they participated in the study. The informant interview is used to ask, in a structured 
way, about those areas of function that are known to deteriorate with the development of 
dementia, for example, memory, general mental functioning, behaviour etc. Where the 
informant notes a problem in a given domain, they are asked whether or not this deficit in 
functioning is new or whether it has always been present. The informant is also asked to give 
examples. Through this approach, a picture of the presence or not of decline across different 
cognitive and functional domains is obtained. The findings from the CAMDEX informant 
interview were subsequently discussed with a clinician (SZ or TH) blind to the age and gender 
of the participant, in order to determine whether or not the participant met the criteria for having 
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developed clinical Alzheimer’s disease as outlined in the International Classification of 
Diseases 10 (ICD). The CAMDEX informant interview has been shown to be valid and reliable 
as a diagnostic tool (S. L. Ball et al., 2004). 
 
Meanwhile, from the CAMCOG-DS neuropsychological assessment, the memory for new 
learning sub-test (scored out of 21) was used in subsequent analyses, given the propensity for 
Alzheimer’s disease to affect this type of memory. Moreover, the subscale for language (scored 
out of 27) was also employed in our analyses. In addition, participants completed a modified 
version of the Tower of London executive function test (Krikorian, Bartok, & Gay, 1994) 
adapted for people with intellectual disability by Ball and colleagues (S. L. Ball, Holland, 
Treppner, Watson, & Huppert, 2008), scored out of 12. IQ was measured using the raw IQ 
scores from the Kaufmann Brief Intelligence Test, 2nd edition (KBIT - II) (Kaufman & 
Kaufman, 2004), since using standard scores would result in many participants scoring at floor 
(Sinai, Hassiotis, Rantell, & Strydom, 2016).  
 
PET Data Acquisition 
All neuroimaging procedures were carried out at the Wolfson Brain Imaging Centre (WBIC), 
University of Cambridge, UK. The presence (or absence) of fibrillar Aβ neuropathology in the 
brains of participants with Down’s syndrome was determined using 11C-PiB PET. All 11C-PiB 
PET scanning and data analysis protocols have been previously described in detail (see Landt 
et al. (2011); Annus et al. (2015)). A brief summary of these procedures can be found in the 
Supplementary material. Based on the outcome of the 11C-PiB PET scan, participants were 
allocated to PiB negative and PiB positive groups on the basis of a bimodal distribution in 
striatal BPND values, as described in Annus et al. (2015). 11C-PiB PET data were not collected 
for typically developing controls.  
 
MRI Data Acquisition 
MRI scans were conducted using a 3T Siemens Verio scanner with a 12-channel head coil. 
Participants underwent a T1 weighted magnetisation prepared rapid gradient echo (MPRAGE) 
scan with the following parameters; TR/TE/TI = 2300/2.98/900ms, FA = 9°, matrix size 240 x 
256, voxel resolution = 1 mm isotropic, receiver bandwidth 240 Hz/pixel, echo spacing 7.1 ms. 
Parallel acceleration was not enabled. Resting state fMRI data were obtained using a T2* 
weighted gradient echo, echo planar imaging (EPI) sequence. A total of 298 volumes were 
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acquired in 31 slices (slice thickness 3 mm) with 3 mm isotropic voxels, using the following 
parameters: TR/TE/ 2000/30 ms, FA = 78°, FOV = 192 mm x 192 mm x 116 mm, matrix size 
= 64 x 64. This sequence lasted for 10 minutes, during which participants were instructed to 
close their eyes but to stay awake. 
 
Resting State fMRI Data Analysis 
Resting state fMRI data were pre-processed using the Statistical Parametric Mapping (SPM) 
v12 software package (http://www.fil.ion.ucl.ac.uk/spm/) based on the v15a MATLAB 
platform (http://www.mathworks.co.uk/products/matlab/). Functional data were slice time and 
motion corrected. Structural T1 images were co-registered to the corresponding mean 
functional image for each participant, and segmented into three tissue classes (grey matter, 
white matter and CSF) using the tissue priors from SPM as input, which were normalised to 
the Montreal Neurological Institute (MNI) 152 space alongside all functional volumes, using 
the unified-segmentation method (Ashburner & Friston, 2005). Finally, images were smoothed 
with an 8 mm FWHM Gaussian kernel. 
 
We anticipated that participants with Down’s syndrome may display substantial movement 
during scanning. Therefore, following recent reports (Ciric et al., 2017), a motion scrubbing 
procedure was implemented using the artefact detection tools (ART) toolbox, to identify 
volumes that were motion outliers, while group differences in motion were tested using two 
measures; the root mean square of frame-to-frame percentage change in BOLD signal 
(DVARS) and mean frame-wise displacement (FD) (Power, Barnes, Snyder, Schlaggar, & 
Petersen, 2012). The CompCorr method of noise reduction (Behzadi, Restom, Liau, & Liu, 
2007) was also employed, whereby five principal components from CSF and white matter noise 
ROIs were entered into the regression analysis as nuisance variables, alongside the motion 
outliers identified by the ART procedure. This was done in place of the using the mean global 
signal as a confounding variable in the GLM, as this can induce spurious negative correlations 
in resting state analysis (Murphy, Birn, Handwerker, Jones, & Bandettini, 2009), and has 
recently been demonstrated to impact variance in the analysis associated with group differences 
(Hahamy et al., 2014).  
 
A seed-based functional connectivity analysis of the DMN to every other voxel in the brain 
was performed using the Conn functional connectivity toolbox (Susan Whitfield-Gabrieli & 
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Nieto-Castanon, 2012), with a spherical medial prefrontal cortex seed (10mm in diameter) 
centred on the following MNI coordinates: [-1, 47, -4]. The medial prefrontal cortex is a hub 
region of the DMN that has been previously used in seed-based investigations of DMN 
connectivity (Keller et al., 2015). In the first level analysis, Pearson correlation coefficients 
between the residual BOLD time-series of the seed region and that of every other voxel in the 
brain were calculated using the general linear model (GLM). These correlation coefficients 
were subsequently Z-transformed, yielding a correlation map for each participant. For 
comparison, an analysis was also carried out using a seed located in the posterior parietal cortex 
(PPC) (see supplementary material). 
 
Second level analysis took the form of within-group t-tests and between groups t-tests to 
identify differences in DMN connectivity between the typically developing control group and 
the whole Down’s syndrome cohort (referred to as Down’s Syndrome [all] in the following 
sections). Additional between-groups tests were conducted to characterise the separate 
contributions of Down’s syndrome and the presence of fibrillar Aβ neuropathology to 
alterations in DMN connectivity. To determine differences in DMN connectivity that were 
principally due to the presence of Down’s syndrome, the PiB negative Down’s syndrome group 
were compared to the control group. Meanwhile, the effects of the presence of fibrillar Aβ on 
DMN connectivity were assessed by comparing the PiB positive and PiB negative Down’s 
syndrome groups to each other. As a supplementary analysis, the compound effect of having 
both Down’s syndrome and fibrillar Aβ neuropathology on DMN connectivity was determined 
through comparing the PiB positive Down’s syndrome group and the control group. All 
reported results are cluster corrected using the Family Wise Error (FWE) detection technique 
at the p < 0.05 level of significance (uncorrected at the voxel level, p < 0.001).  
 
The relationships between DMN connectivity and various demographic and cognitive 
measures were investigated in the Down’s syndrome (all) group using a whole-brain GLM 
approach. To do this, connectivity maps for the Down’s syndrome (all) group were entered into 
a one-sample t-test with each metric (age, raw IQ score, memory for new learning, language, 
and Tower of London executive function task score). Due to variations in the severity of 
intellectual disability and/or cognitive decline among participants with Down’s syndrome, 
some participants were unable to complete all tests. Therefore, while the number of participants 
included varied from test to test, the minimum number of participants included in each analysis 
was 30. All measures were mean centred, and both positive and negative contrasts were 
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specified to investigate connections that were both positively and negatively associated with 
task performance. To determine the strength of the correlation, connectivity values from the 
peak voxel of each significant cluster were extracted and entered into a Spearman correlation 
analysis alongside the mean centred neuropsychological test scores. 
 
Statistical Analysis 
Statistical tests were carried out using the IBM SPSS statistics package, Version 22 
(https://www.ibm.com/products/spss-statistics). Due to the non-normal distribution of a 
number of variables in the dataset, non-parametric statistics were employed. Differences in age 
between the typically developing control and Down’s syndrome (all) groups were investigated 
using the Mann-Whitney U test. This test was also used to investigate differences between the 
PiB negative Down’s syndrome and PiB positive Down’s syndrome groups in raw IQ score, 
memory for new learning, language, and performance on the Tower of London executive 
function task.  
 
Meanwhile, differences in gender distribution across three groups (i.e. typically developing 
controls, PiB negative Down’s syndrome and PiB positive Down’s syndrome) were 
investigated using the chi-square test of association, while statistical differences in age across 
these three groups were investigated using the Kruskal-Wallis H test, followed by post-hoc 
tests using Dunn’s procedure. Finally, the relationship between performance on tests of 
IQ/cognitive function and default mode connectivity in the Down’s syndrome (all) group was 
investigated using a whole-brain approach in SPM. 
 
Data Availability Statement 
Raw data were generated at the Wolfson Brain Imaging Centre, University of Cambridge, UK. 
Derived data supporting the findings of the study are available from the corresponding author 









There were no statistically significant differences between the typically developing control and 
Down’s syndrome (all) groups in terms of age (U = -0.224, p = 0.823) or gender distribution 
(χ2 = 0.318, p = 0.573).  As expected, the two groups differed significantly in terms of motion 
during scanning, with the Down’s syndrome (all) group showing a greater number of volumes 
affected by motion (see Supplementary Table S1). 
 
Default Mode Network in Down’s Syndrome 
Our first aim was to determine the differences between typically developing controls and 
people with Down’s syndrome irrespective of Aβ pathology. As such, the initial analyses 
investigated DMN connectivity within and between the typically developing and Down’s 
syndrome (all) groups.  
 
The within group profiles of DMN connectivity (using the medial prefrontal cortex seed) in 
these two groups can be seen in Figure 1. While this analysis yielded the expected pattern of 
DMN connectivity for the control group (Andrews-Hanna, 2012), the Down’s syndrome (all) 
group did not display a typical profile of DMN connectivity. Rather, functional connectivity of 
the DMN seed to the rest of the brain was far more extensive in the Down’s syndrome (all) 
group. Furthermore, although the control group displayed a similar pattern of anti-correlation 
with the DMN to that seen in previous studies (Fox et al., 2005), there was a strikingly different 
pattern of anti-correlation with the DMN in the Down’s syndrome (all) group, in that almost 







Figure 1. Within group default mode network connectivity in A) typically developing age-matched 
controls and B) all participants with Down’s syndrome. The statistical maps (T-scores) represent 
positive correlation (red) and anti-correlation (blue) of the medial prefrontal cortex (mPFC) seed 
region (connectivity with subcortical structures and cerebellum is not shown).  
 
To quantify the differences seen in the within groups analysis, paired comparisons were 
conducted between the typically developing control group and the Down’s syndrome (all) 
cohort. The contrast of controls > Down’s syndrome (all) showed that the latter group had 
reduced (i.e. weaker) connectivity between the DMN (medial prefrontal cortex seed) in the 
following regions: the right precuneus/posterior cingulate, the left calcarine and the right 
anterior cingulate cortices, the medial superior frontal gyrus, as well as region 9 of the 
cerebellum (Fig. 2A). Conversely, the contrast of Down’s syndrome (all) > controls revealed 
positive connectivity in the Down’s syndrome group to regions that were anti-correlated with 
the DMN in the control group (Fig. 2B). Greater positive DMN connectivity in the Down’s 
syndrome (all) group was seen in the pars orbitalis and triangularis of the middle frontal gyrus, 
the middle temporal gyrus, the supplementary motor area bilaterally, the left precentral gyrus, 
the right inferior occipital cortex, and the right putamen. However, other regions were strongly 
anti-correlated in the control group but were only weakly correlated with the DMN in the 
Down’s syndrome (all) group, including regions of parietal lobes bilaterally, region 7b of the 
cerebellum bilaterally, and the right precuneus. Finally, there was strong connectivity of the 
DMN to the left medial superior frontal gyrus in the Down’s syndrome (all) group that was not 




Figure 2. Differences in default mode network connectivity (mPFC seed) between the typically 
developing control and Down’s syndrome groups, showing A) controls > Down’s syndrome (all), and 
B) Down’s syndrome (all) > typically developing controls. Where prefixed to the abbreviation of a 
brain region, L and R indicate the left and right hemisphere, respectively. ACG – anterior cingulate 
gyrus; CAL – Calcarine cortex; CER9 – region 9 of the cerebellum; CER7b – region 7 of the 
cerebellum; IFG – inferior frontal gyrus; IOG – inferior occipital gyrus; ITG – inferior temporal 
gyrus; MFG – inferior/middle frontal gyrus; MTG – middle temporal gyrus; PAL – Pallidum; PCG – 
posterior cingulate gyrus; PCUN – precuneus; PreCG – precentral gyrus; SFGmed – medial superior 
frontal gyrus; SMA – supplementary motor area; SMG – supramarginal gyrus; SPG – superior 
parietal gyrus. 
 
Default mode alterations in the absence/presence of fibrillar Aβ neuropathology 
It has been well established that Alzheimer’s disease affects the connectivity of the DMN 
(Buckner et al., 2005; Greicius et al., 2004; S. Whitfield-Gabrieli & Ford, 2012). Therefore, to 
determine the effects of the accumulation of Alzheimer’s disease neuropathology, specifically 
fibrillar Aβ, on DMN connectivity in people with Down’s syndrome, the Down’s syndrome 
(all) group was divided into those negative and positive for cerebral fibrillar Aβ, as determined 
by 11C-PiB PET.  A Kruskal-Wallis H test indicated a statistically significant effect of age 
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across the three groups (χ2 = 10.074, p = 0.006), with post-hoc tests using Dunn’s procedure 
and the Bonferroni correction for multiple comparisons indicating that this was driven by a 
difference between the PiB negative and PiB positive Down’s syndrome groups (with a median 
age of 42 and 48, respectively, p = 0.005). Further demographic and neuropsychological data 
for the PiB negative and PiB positive Down’s syndrome groups are shown in Table 2. 
 
Table 2 – Demographic data and neuropsychological test results for PiB negative and PiB positive 
Down’s syndrome groups.  
 TD 
Controls 
PiB –ve PiB +ve Effect size P 
Number  20 19 15 - - 
Gender (% female) 45 57 46.67 χ2 = 0.740 0.691 
Age  43.5 41.0 48.0** χ2 = 10.074 0.006 
Age range 30-55 30-48 39-55 - - 
DVARS 25.5 31.87* 37.85* χ2 = 26.467 < 0.0005 
FD 0.17 0.34* 0.39* χ2 = 24.512 < 0.0005 
Raw IQ - 56 60 U  = 107.5 0.482 
Tower of London - 9 6.5 U = 64.5 0.018 
New learning - 14 9 U = 70.5 0.011 
Language - 15 15 U = 97 0.111 
Number with 
dementia 
- 3 5 - - 
TD – typically developing; PiB –ve – PiB negative; PiB +ve – PiB positive; IQ = intelligence quotient; 
FD = Frame-wise displacement. 
* Significantly different from controls at the level of p < 0.0005 
** Significantly different from PiB negative Down’s syndrome at the level of p < 0.005 
 
To investigate the effects of Down’s syndrome (i.e. in the absence of fibrillar Aβ 
neuropathology) on DMN connectivity, the PiB negative group were compared to the typically 
developing control group. The contrast of controls > PiB negative Down’s syndrome showed 
the latter group had reduced connectivity between the DMN (medial prefrontal cortex seed) 
and the left anterior cingulate (Fig. 3). The reverse contrast, however, revealed greater positive 
DMN connectivity in the Down’s syndrome group in a distribution of regions that were anti-
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correlated with the DMN in the control group, and highly similar to that seen in the comparison 
between the controls and the whole Down’s syndrome group (all) described above. 
 
 
Figure 3. Differences in default mode network connectivity between typically developing controls and 
PiB negative participants with Down’s syndrome, showing A) Controls > PiB-ve Down’s syndrome, 
and B) PiB-ve Down’s syndrome > controls. PiB-ve – PiB negative; Where prefixed to the 
abbreviation of a brain region, L and R indicate the left and right hemisphere, respectively. 
Furthermore, a suffix of 1 or 2 to an abbreviation serves to differentiate different significant clusters 
located within a single brain region. ACG – anterior cingulate gyrus; CERcr2 – Cerebellum crus 2; 
CER7b – region 7b of the cerebellum; ITG – inferior temporal gyrus; MFG – middle frontal gyrus; 
MTG – middle temporal gyrus; ORBmid – middle orbitofrontal gyrus; PHG – parahippocampal 







Meanwhile, to determine the effect of Aβ neuropathology (i.e. exclusive of the effects of 
Down’s syndrome), the PiB positive Down’s syndrome group were compared to the PiB 
negative Down’s syndrome group. The contrast of PiB negative Down’s syndrome > PiB 
positive Down’s syndrome showed that the PiB positive group had reduced DMN connectivity 
to the precuneus and posterior cingulate cortex, as well as to a region of the right middle 
temporal gyrus (Fig. 4). However, the reverse contrast did not reveal any statistically 
significant differences.  
 
 
Figure 4. Differences in default mode network connectivity between the PiB negative and PiB 
positive Down’s syndrome groups (PiB negative > PiB positive). The reverse contrast is not shown. 
PiB –ve – PiB negative; PiB +ve – PiB positive; RMTG – right middle temporal gyrus; RPCUN – 
right precuneus.   
 
Finally, a comparison of the typically developing control and PiB positive Down’s syndrome 
groups was conducted to investigate the compound effects of Down’s syndrome and Aβ 
neuropathology on DMN connectivity. The PiB positive Down’s syndrome group had reduced 
DMN connectivity to the precuneus and posterior cingulate cortex, the anterior cingulate, 
region 9 of the right cerebellum and the left medial superior frontal gyrus (Fig. 5), as well as 
to regions of the left parahippocampal gyrus, left amygdala, and the hippocampus and thalamus 
bilaterally. Meanwhile, the reverse contrast showed that the PiB positive Down’s syndrome 
group had positive DMN connections to many regions which were anti-correlated with the 
DMN in the control group, including the inferior and superior parietal lobules, the middle 
frontal gyri, and the right inferior temporal gyrus. 
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Figure 5. Default mode network connectivity in the PiB positive Down’s syndrome group compared 
to the typically developing control group, showing A) controls > PiB positive Down’s syndrome, and 
B) PiB negative Down’s syndrome > controls. PiB +ve – PiB positive; prefixed to the abbreviation of 
a brain region, L and R indicate the left and right hemisphere, respectively. Furthermore, a suffix of 1 
or 2 to an abbreviation serves to differentiate different significant clusters located within a single brain 
region. ACG – anterior cingulate gyrus; CER9 – region 9 of the cerebellum; IFGtriang – inferior 
frontal gyrus pars triangularis; IOG – inferior occipital gyrus; IPL – inferior parietal lobule; ITG – 
inferior temporal gyrus; MTG – middle temporal gyrus; PCUN – precuneus; SFGmed – medial 
superior frontal gyrus; SMA – supplementary motor area; SPG – superior parietal gyrus.  
 
Association of default mode alterations and cognitive performance 
As the Down’s syndrome (all) group also represented various degrees of risk for cognitive 
decline and Alzheimer’s disease, the relationship of DMN connectivity to IQ and cognition 
were investigated in this group (Fig. 6) using a whole-brain approach in SPM. There was a 
strong positive correlation between DMN connectivity to the right thalamus and raw IQ score 
(r = 0.674, p < 0.0001), memory for recently learned information (r = 0.721, p < 0.0001), and 
language (r = 0.681, p < 0.0001), indicating that better scores on tests measuring these faculties 
were correlated with stronger connectivity between the DMN and the right thalamus. Language 
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score also correlated positively with DMN connectivity to the left middle cingulate and 
posterior cingulate cortex (r = 0.627, p < 0.0001), the right middle frontal gyrus (r = 0.570, p 
< 0.0004), and regions 4 and 5 of the left cerebellum (r = 0.400, p < 0.0190). There was no 
association between DMN connectivity and scores on the Tower of London test of executive 
function.  
 
Figure 6 – Correlations between IQ, memory and language and default mode network (DMN) 





Overall, the results of this study highlight widespread alterations in the connectivity of the 
DMN in people with Down’s syndrome. Pairwise comparisons between the Down’s syndrome 
(all) group and the typically developing controls revealed a pattern of weaker connectivity in 
the Down’s syndrome group between the DMN seed and a number of regions, including the 
posterior cingulate/precuneus, as well as the anterior cingulate, the left calcarine cortex, the 
medial superior frontal gyrus, and part of the cerebellum. Furthermore, dividing the Down’s 
syndrome population into those negative and positive for fibrillar Aβ neuropathology as 
determined by 11C-PiB PET indicated that reductions in the strength of DMN connectivity to 
frontal brain regions may be largely associated with Down’s syndrome, while reductions in 
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DMN connectivity to posterior brain regions are linked to the presence of Alzheimer’s disease 
neuropathology.  
 
Notably, this last result suggests that the findings of this study may have a wider significance 
(i.e. extending to other Alzheimer’s disease patient populations) as the pattern of reduced 
connectivity in the presence of Alzheimer’s disease pathology in the PiB positive Down’s 
syndrome group was reminiscent of that which has been shown to occur in sporadic and 
familial Alzheimer’s disease (Chhatwal et al., 2013; Gili et al., 2011; Greicius et al., 2004; He 
et al., 2007; Yi et al., 2015; Zhou et al., 2010). That is, the alterations in DMN connectivity 
seen in this study encompassed regions including the posterior cingulate cortex and precuneus, 
a part of the brain that also shows altered metabolic function in people with Alzheimer’s disease 
and is a key site of Aβ deposition (Buckner et al., 2009; Buckner et al., 2005). As such, this 
study serves to highlight the similarities in the effects of Alzheimer’s disease on the brains of 
people with Down’s syndrome and typically developing controls, indicating the utility of 
involving people with Down’ syndrome in research, since the development of Alzheimer’s 
disease can more readily be predicted in this patient population, but the results may be, in large 
part, generalisable.  
 
Alterations in the DMN connectivity of the posterior cingulate cortex and precuneus have also 
been seen in an asymptomatic population at high risk for Alzheimer’s disease compared to 
asymptomatic individuals with no increased risk (Chhatwal et al., 2013). This is particularly 
interesting given the largely preclinical nature of the cohort involved in the present study, and 
taken together these findings may corroborate the notion that disrupted functional connectivity 
of the DMN is an early biomarker of Alzheimer’s disease neuropathology. However, this 
finding was not replicated in a subsequent study that included slightly younger asymptomatic 
populations at risk of sporadic Alzheimer’s disease due to the presence of the risk allele APOE 
ε4 (Thomas et al., 2014). Yet it must be noted that in the case of the study of a familial 
autosomal dominant Alzheimer’s disease cohort by Chhatwal et al. (2013), and in the case of 
people with Down’s syndrome as in the present study, the onset of Alzheimer’s disease 
neuropathology is a near certainty provided that the required mutation or additional copy of 
APP is present, and therefore may represent a qualitatively different population to those with 
other risk factors such as APOE ε4 alleles, which are not determinant but greatly increase risk.  
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Thus, the similarities between the present findings and those of other studies involving different 
clinical populations further highlight the candidacy of people with Down’s syndrome for future 
Alzheimer’s disease research. Moreover, given that the development of neuropathology is more 
predictable in this cohort as compared to sporadic Alzheimer’s disease, the design of clinical 
trials for preventative treatments may be less costly and more efficient. However, before any 
such future studies can be carried out, it is necessary to consider the problem inherent in all 
Alzheimer’s disease research, but which is particularly relevant when conducting studies 
involving people with Down’s syndrome; that is, the problem of age. Given the robust link 
between age and amyloid deposition in people with Down’s syndrome, effects attributed to the 
presence of amyloid cannot readily be disentangled from effects due to age. In the present 
study, age was not entered as a covariate into the present analysis for this very specific reason, 
since by removing the effect of age from any analysis, one is certain to also remove a great 
deal of variance that may be due to the presence of Aβ neuropathology.  
 
Furthermore, while the findings of the present study bring to light important new information 
regarding DMN connectivity in people with Down’s syndrome in relation to the development 
of amyloid pathology, this study also has implications for future investigations of DMN 
connectivity in people with Down’s syndrome from a developmental perspective. Our results 
demonstrated a highly atypical DMN in people with Down’s syndrome, characterised by 
widespread positive connectivity (i.e. hyper-connectivity) coupled with a striking reduction in 
anti-correlation. This effect was noticeable in the within group analysis of DMN connectivity 
for the Down’s syndrome (all) group, but was also emphasised by the between group analysis 
contrasting the Down’s syndrome (all) group and typically developing controls. This latter 
comparison showed positive connectivity of the DMN in this Down’s syndrome group to 
regions that were negatively correlated with the DMN in the control group. Notably, once the 
Down’s syndrome (all) group was divided into those negative and positive for the presence of 
fibrillar Aβ neuropathology, the hyper-connectivity effect was seen most prominently in the 
PiB negative Down’s syndrome group, indicating that it may be the de-facto, pre-morbid (i.e. 
pre-Alzheimer’s disease) state of the DMN in this population. 
 
This pattern of DMN hyper-connectivity is similar to findings reported from previous fMRI 
investigations of brain connectivity involving people with Down’s syndrome (Anderson et al., 
2013; Vega et al., 2015). These studies found increased inter-network connectivity in people 
with Down’s syndrome compared to controls, including greater positive connectivity between 
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the default mode network and numerous other large-scale functional brain networks. Together, 
these studies suggest that the organisation of the brain into segregated networks (Fox et al., 
2005) is highly disrupted in people with Down’s syndrome.  
 
Whether and how this hyper-connectivity of the DMN is related to developmental cognitive 
dysfunction and intellectual disability seen in people with Down’s syndrome is an important 
question, and one that should be taken up by future research. The present study may act as a 
catalyst for such studies, having found associations between performance on tests of IQ, 
memory for new learning, language and DMN connectivity to various regions, most 
prominently the right thalamus.  
 
As noted above, the hyper-connectivity of the DMN in people with DS revealed in this study 
was coupled with a lack of anti-correlation with the DMN. In the control group, the presence 
of a network that is anti-correlated with the DMN was evident from the within-group analysis, 
and encompassed many of the regions of the “task-positive network,” described by Fox et al. 
(2005). Notably, the exact physiological nature of the anti-correlation between brain networks 
is still under debate (Chai, Castanon, Ongur, & Whitfield-Gabrieli, 2012; Murphy et al., 2009), 
with recent publications highlighting their potential biological basis (Fox, Zhang, Snyder, & 
Raichle, 2009; Keller et al., 2015; Spreng, Stevens, Viviano, & Schacter, 2016), and indicating 
that they may provide a level of segregation between two major brain systems for healthy 
cognitive processing (Gao & Lin, 2012; Uddin, Kelly, Biswal, Castellanos, & Milham, 2009; 
Vatansever et al., 2017).  
 
The notion that anti-correlation between functionally distinct networks is necessary for normal 
brain function is somewhat intuitive, as it neatly lends itself to a mechanism by which distinct 
functional networks can be organised and segregated within the brain (Fox et al., 2005). 
Furthermore, it is an idea that is given some weight by consistent findings of reductions in anti-
correlation with the DMN in other brain disorders, including Alzheimer’s disease (Wang et al., 
2007), attention-deficit/hyperactivity disorder (Castellanos et al., 2008), autism (Anderson et 
al., 2011), schizophrenia (S. Whitfield-Gabrieli et al., 2009), and behavioural fronto-temporal 
dementia (Hafkemeijer et al., 2015). Thus, the hyper-connectivity of the DMN in people with 
Down’s syndrome (although largely weaker than in controls in areas such as the anterior 
cingulate) and the (almost) complete absence of anti-correlation may be a large contributing 
factor to the disorganisation of the DMN in this group of people.  
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Finally, it is important to consider the differences in brain morphology between people with 
Down’s syndrome and typically developing controls, and its possible impact on functional 
connectivity estimates. 
 
A number of volumetric MRI studies primarily employing ROI-based approaches (please see 
Annus et al., 2017 for a summary) have identified reduced overall grey matter volumes in 
people with Down’s syndrome relative to controls (Beacher et al., 2010; Pearlson et al., 1998; 
White, Alkire, & Haier, 2003), while specific reductions in volume have also been reported in 
the frontal lobes, the hippocampus and the cerebellum (Aylward et al., 1999; Beacher et al., 
2010; Koran et al., 2014; Pearlson et al., 1998; White et al., 2003). Meanwhile, increases in 
grey matter volume have been noted in the parahippocampal gyrus and in the parietal and 
occipital cortices (Beacher et al., 2010; White et al., 2003).  
 
Notably, however, where cortical thickness in Down’s syndrome is concerned, Annus and 
colleagues (2017) have demonstrated that those without fibrillar amyloid (as determined using 
PiB PET) show a thickening of the cortex relative to typically developing controls in the lateral 
and medial frontal, parietal and occipital cortices, and in the region of the precuneus/posterior 
cingulate cortex. These findings have been corroborated to some degree in a recent study by 
Levman et al. (2019) of infants, children and young adults with Down’s syndrome, which found 
thicker cortex in the participants with Down’s syndrome in frontal regions, among others, 
including Brodmann’s area, the medial and lateral orbitofrontal cortex and the anterior 
cingulate.  
 
Meanwhile, markedly reduced cortical thickness was seen by Annus and colleagues (2017) in 
PiB positive participants with Down’s syndrome (relative to the PiB negative group) in 
posterior regions including the precuneus and posterior cingulate, and the parietal, occipital 
and posterior temporal lobes, indicating a pattern of thinning in this group remarkably similar 
to that seen in sporadic Alzheimer’s disease (Annus et al., 2017). 
 
Due to concerns regarding these morphological differences between the brains of people with 
Down’s syndrome and the typically developing population, the present study included a 
supplementary analysis using a seed centred on the posterior parietal cortex (PPC) [MNI: -5, -
51, 39], to determine whether the choice of an mPFC seed may be unduly influencing the 
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results. While the results of this analysis (displayed in Supplementary Figure S1) show a 
slightly different pattern of default mode connectivity differences in the Down’s syndrome 
group relative to controls, with more posterior dominance, the overall direction of results 
remains the same, with substantial regions of reduced anti-correlation to the DMN being seen 
in participants with Down’s syndrome. Moreover, when comparing the PiB negative and PiB 
positive Down’s syndrome groups using the PPC seed, a near identical pattern of results to that 
obtained using the mPFC seed is observed, in that the PiB positive group showed a specific 
reduction in positive connectivity of the PPC seed to the posterior cingulate cortex. As such, 
the results of this additional analysis indicate that the differences we have observed in this 
study can be generalised to the whole DMN and are not likely to be the consequence of 
differences in brain morphology or the selection of a specific seed region. Furthermore, the 
findings of Annus et al. (2017) regarding cortical thinning in PiB positive participants with 
Down’s syndrome in the regions encompassing the PPC seed indicate that the use of an mPFC 
seed for comparing DMN connectivity between these two groups is the more appropriate 
choice. 
 
In summary, the present study has demonstrated widespread disruption of the DMN in people 
with Down’s syndrome, which is further altered in the presence of Aβ neuropathology in a 
pattern that is reminiscent of that seen in other populations with Alzheimer’s disease. The 
significance of these findings may be further highlighted given the largely preclinical nature of 
our cohort, indicating that functional connectivity of the DMN may be useful in future studies 
as an early biomarker of altered neuronal function due to Alzheimer’s disease.  
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